Advertisement

Topics

Seres Therapeutics shares falter on $60M secondary public offering

07:22 EDT 14 Jun 2019 | Proactive Investors

The microbiome drugmaker will offer 26.6 million shares at a price of $2.25 per share

Original Article: Seres Therapeutics shares falter on $60M secondary public offering

NEXT ARTICLE

More From BioPortfolio on "Seres Therapeutics shares falter on $60M secondary public offering"

Advertisement
Quick Search
Advertisement
Advertisement